» Articles » PMID: 29967775

The Bioactive Substance Secreted by MSC Retards Mouse Aortic Vascular Smooth Muscle Cells Calcification

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Jul 4
PMID 29967775
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular calcification, which is associated with low-level chronic inflammation, is a complication that occurs during aging, atherosclerosis, chronic kidney disease, diabetes mellitus, and hyperlipaemia. In this study, we used conditioned media from mesenchymal stem cells (MSC-CM), a source of autologous cytokines, to test the hypothesis that MSC-CM inhibits vascular smooth muscle cell (VSMC) calcification by suppressing inflammation and apoptosis.

Methods: VSMCs were treated with -glycerophosphate (-GP) to induce calcification and MSC-CM was used as a treatment. Calcium deposition was evaluated using alizarin red and von Kossa staining after a 7-day induction period. Intracellular calcium contents were measured via the o-cresolphthalein complexone method, and alkaline phosphatase (ALP) activity was determined using the para-nitrophenyl phosphate method. The expressions of specific-osteogenic markers, inflammatory cytokines, and apoptosis-associated genes/proteins were examined by real-time polymerase chain reaction or western blotting.

Results: MSC-CM inhibited -GP-induced calcium deposition in VSMCs and decreased intracellular calcium content and ALP activity. Additionally, MSC-CM suppressed the -GP-induced increases in BMP2, Msx2, Runx2, and osteocalcin expression. Additionally, MSC-CM decreased the expression of TNF-, IL-1, and IL-6 in VSMC. MSC-CM also partly blocked -GP-induced VSMC apoptosis, which was associated with an increase in the Bcl-2/Bax expression ratio and a decrease in caspase-3 expression.

Conclusion: Our study results suggest that MSC-CM can inhibit VSMC calcification. This suggests a potential novel clinical application for MSCs in the treatment of vascular calcification and associated diseases.

Citing Articles

Advances in Pathophysiological Mechanisms of Degenerative Aortic Valve Disease.

Yu Y, Jiang Q Cardiol Res. 2025; 16(2):86-101.

PMID: 40051666 PMC: 11882237. DOI: 10.14740/cr2012.


Mesenchymal Stem Cell-Conditioned Media-Loaded Microparticles Enhance Acute Patency in Silk-Based Vascular Grafts.

Lorentz K, Marini A, Bruk L, Gupta P, Mandal B, DiLeo M Bioengineering (Basel). 2024; 11(9).

PMID: 39329689 PMC: 11428691. DOI: 10.3390/bioengineering11090947.


Mesenchymal Stem Cell-conditioned Medium Protecting Renal Tubular Epithelial Cells by Inhibiting Hypoxia-inducible Factor-1α and Nuclear Receptor Coactivator-1.

Liao C, Liu Y, Lin Y, Wang J, Zhou T, Weng W Curr Stem Cell Res Ther. 2023; 19(10):1369-1381.

PMID: 37817516 DOI: 10.2174/011574888X247652230928064627.


Mechanism Analysis of Vascular Calcification Based on Fluid Dynamics.

Xu S, Wang F, Mai P, Peng Y, Shu X, Nie R Diagnostics (Basel). 2023; 13(16).

PMID: 37627891 PMC: 10453151. DOI: 10.3390/diagnostics13162632.


Development of stem cell therapy for atherosclerosis.

Ma Y, Gu T, He S, He S, Jiang Z Mol Cell Biochem. 2023; 479(4):779-791.

PMID: 37178375 DOI: 10.1007/s11010-023-04762-8.


References
1.
Zhao G, Xu M, Zhao M, Dai X, Kong W, Wilson G . Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int. 2012; 82(1):34-44. PMC: 3376207. DOI: 10.1038/ki.2012.40. View

2.
Durham A, Speer M, Scatena M, Giachelli C, Shanahan C . Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018; 114(4):590-600. PMC: 5852633. DOI: 10.1093/cvr/cvy010. View

3.
Lanzer P, Boehm M, Sorribas V, Thiriet M, Janzen J, Zeller T . Medial vascular calcification revisited: review and perspectives. Eur Heart J. 2014; 35(23):1515-25. PMC: 4072893. DOI: 10.1093/eurheartj/ehu163. View

4.
Deuell K, Callegari A, Giachelli C, Rosenfeld M, Scatena M . RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. J Vasc Res. 2012; 49(6):510-21. PMC: 4001814. DOI: 10.1159/000341216. View

5.
Shao J, Cai J, Towler D . Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006; 26(7):1423-30. DOI: 10.1161/01.ATV.0000220441.42041.20. View